Acute renal failure after bilateral nephrectomy is associated with cytokine-mediated pulmonary injury.

Clinical studies demonstrate that acute renal failure (ARF) is associated with increased mortality, which may be due to pulmonary complications. ARF may affect the lung via increased renal production or impaired clearance of mediators of lung injury, such as proinflammatory cytokines. Bilateral nephrectomy is a method to examine directly the deleterious systemic effects of absent renal clearance in ARF without the confounding effects that are associated with ischemia-reperfusion injury (e.g., ischemic ARF) or systemic toxicity (e.g., cisplatin-induced ARF). This study contrasts the effects of ischemic ARF and bilateral nephrectomy on serum cytokines and lung injury. It demonstrates that the acute absence of kidney function after both ischemic ARF and bilateral nephrectomy is associated with an increase in multiple serum cytokines, including IL-6 and IL-1beta, and that the cytokine profiles were distinct. Lung injury after ischemic ARF and bilateral nephrectomy was similar and was characterized by pulmonary vascular congestion and neutrophil infiltration. For investigation of the role of proinflammatory cytokines in pulmonary injury after ARF, the anti-inflammatory cytokine IL-10 was administered before bilateral nephrectomy. IL-10 treatment improved pulmonary architecture and was associated with a reduction in inflammatory markers, including bronchoalveolar lavage fluid total protein, pulmonary myeloperoxidase activity (a biochemical marker of neutrophils), and the chemokine macrophage inflammatory protein 2. These data demonstrate for the first time that the acute absence of kidney function results in pulmonary injury independent of renal ischemia and highlight the critical role of the kidney in the maintenance of serum cytokine balance and pulmonary homeostasis.

[1]  J. Richardson,et al.  Maladaptive role of IL-6 in ischemic acute renal failure. , 2005, Journal of the American Society of Nephrology : JASN.

[2]  L. King,et al.  Keratinocyte-derived chemokine is an early biomarker of ischemic acute kidney injury. , 2006, American journal of physiology. Renal physiology.

[3]  M. Burdick,et al.  Chemokine expression during hepatic ischemia/reperfusion-induced lung injury in the rat. The role of epithelial neutrophil activating protein. , 1995, The Journal of clinical investigation.

[4]  V. Bocci Interleukins. Clinical pharmacokinetics and practical implications. , 1991, Clinical pharmacokinetics.

[5]  R. Star,et al.  D-melanocyte Stimulating Hormone Inhibits Lung Injury after Renal Ischemia- Reperfusion , 2022 .

[6]  A. Lentsch,et al.  Enhanced pulmonary expression of CXC chemokines during hepatic ischemia/reperfusion-induced lung injury in mice. , 1999, The Journal of surgical research.

[7]  C. Smith,et al.  Role of beta 2 integrins and ICAM-1 in lung injury following ischemia-reperfusion of rat hind limbs. , 1993, The American journal of pathology.

[8]  C. Edelstein,et al.  Neutrophil-independent mechanisms of caspase-1- and IL-18-mediated ischemic acute tubular necrosis in mice. , 2002, The Journal of clinical investigation.

[9]  R. Colvin,et al.  Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[10]  G. Pessina,et al.  The renal catabolic pathways of cytokines. , 1993, Contributions to nephrology.

[11]  T. Ikejima,et al.  Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. , 1988, The Journal of clinical investigation.

[12]  D. Prezant Effect of uremia and its treatment on pulmonary function , 1990, Lung.

[13]  J. Mege,et al.  IL-10 synthesis and secretion by peripheral blood mononuclear cells in haemodialysis patients. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[14]  R. Colvin,et al.  Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. , 1996, The Journal of clinical investigation.

[15]  C. Viscoli,et al.  The Effect of Acute Renal Failure on Mortality , 1997 .

[16]  W. Buurman,et al.  APOPTOSIS AND CHEMOKINE INDUCTION AFTER RENAL ISCHEMIA-REPERFUSION1 , 2001, Transplantation.

[17]  P. Hirth,et al.  Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. , 2000, The Journal of clinical investigation.

[18]  R. Strieter,et al.  Tumor necrosis factor up-regulates intercellular adhesion molecule 1, which is important in the neutrophil-dependent lung and liver injury associated with hepatic ischemia and reperfusion in the rat. , 1998, Shock.

[19]  J. le Gall,et al.  Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients* , 2002, Critical care medicine.

[20]  John A Kellum,et al.  Acute renal failure in critically ill patients: a multinational, multicenter study. , 2005, JAMA.

[21]  K. Karalis,et al.  Stress-induced interleukin-6 release in mice is mast cell-dependent and more pronounced in Apolipoprotein E knockout mice. , 2003, Cardiovascular research.

[22]  C. Valeri,et al.  Role for tumor necrosis factor as mediator of lung injury following lower torso ischemia. , 1991, Journal of applied physiology.

[23]  C. Edelstein,et al.  Peripheral CD4 T-Cell Depletion Is Not Sufficient to Prevent Ischemic Acute Renal Failure , 2005, Transplantation.

[24]  H. Tanaka,et al.  PHARMACOKINETICS OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR (KRN8601) IN THE RAT , 1991 .

[25]  L. Bachmann,et al.  Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. , 2004, Journal of the American Society of Nephrology : JASN.

[26]  D. Meijer,et al.  Pharmacokinetic and Biodistribution Profile of Recombinant Human Interleukin-10 Following Intravenous Administration in Rats with Extensive Liver Fibrosis , 2004, Pharmaceutical Research.

[27]  C. Viscoli,et al.  The effect of acute renal failure on mortality. A cohort analysis. , 1996, JAMA.

[28]  K E Hammermeister,et al.  Independent association between acute renal failure and mortality following cardiac surgery. , 1998, The American journal of medicine.

[29]  T. Bird,et al.  Fate of injected interleukin 1 in rats: sequestration and degradation in the kidney. , 1990, Cytokine.

[30]  J. Parienti,et al.  The attributable mortality of acute renal failure in critically ill patients with liver cirrhosis , 2005, Intensive Care Medicine.

[31]  R. Schrier,et al.  Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. , 2004, The Journal of clinical investigation.

[32]  H. Rabb,et al.  Renal ischemia/reperfusion leads to macrophage-mediated increase in pulmonary vascular permeability. , 1999, Kidney international.

[33]  W. Buurman,et al.  Ischemia/reperfusion-induced IFN-gamma up-regulation: involvement of IL-12 and IL-18. , 1999, Journal of Immunology.

[34]  D. Thickett,et al.  Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome. , 2001, American journal of respiratory and critical care medicine.

[35]  E. Shpall,et al.  Renal dysfunction in allogeneic hematopoietic cell transplantation. , 2002, Kidney international.

[36]  H. Suzuki,et al.  Interleukin-10 production during and after upper abdominal surgery. , 1998, Journal of clinical anesthesia.

[37]  E. Honkanen [Treatment of acute renal failure]. , 1998, Duodecim; laaketieteellinen aikakauskirja.

[38]  C. Davis,et al.  Pharmacokinetics and tissue distribution of SB-251353, a novel human CXC chemokine, after intravenous administration to mice. , 2001, The Journal of pharmacology and experimental therapeutics.

[39]  H. Suzuki,et al.  Elevated plasma levels of interleukin-6, interleukin-8, and granulocyte colony-stimulating factor during and after major abdominal surgery. , 1997, Journal of clinical anesthesia.

[40]  D. Bates,et al.  Mortality and costs of acute renal failure associated with amphotericin B therapy. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[41]  N. Thornberry The caspase family of cysteine proteases. , 1997, British medical bulletin.

[42]  Emil,et al.  Plasma cytokine levels predict mortality in patients with acute renal failure. , 2004, Kidney international.